| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.6M | +0.6% |
| Cost of Revenue | $14.5M | -2.8% |
| Gross Profit | $19.1M | +3.4% |
| R&D Expense | $883K | -33.0% |
| SG&A Expense | $11.3M | +7.6% |
| Operating Income | -$9.3M | -7.6% |
| Pre-tax Income | -$10.3M | +6.1% |
| Income Tax | -$170K | -84.8% |
| Net Income | -$10.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | +7.0% |
| Accounts Receivable | $5.3M | +18.3% |
| Inventory | $2.2M | -16.0% |
| Current Assets | $16.6M | +6.8% |
| Total Assets | $36.2M | -13.9% |
| Current Liabilities | $14.6M | +20.1% |
| Long-term Debt | $15.0M | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $188K | +136.2% |
| Capital Expenditures | $1.6M | -67.4% |
| Investing Cash Flow | -$1.6M | +67.4% |
| Financing Cash Flow | $1.9M | -71.9% |
| Free Cash Flow | -$1.4M | +73.9% |
| +6.9% |
| EPS (Basic) | -$2.65 | -754.8% |
| EPS (Diluted) | -$2.65 | -754.8% |
| Total Liabilities |
| $31.2M |
| +6.3% |
| Stockholders' Equity | $5.0M | -60.8% |